LEPU MED.T.B. SP.GDR O.N. (07Z0) - Total Assets
Based on the latest financial reports, LEPU MED.T.B. SP.GDR O.N. (07Z0) holds total assets worth €25.59 Billion EUR (≈ $29.91 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
LEPU MED.T.B. SP.GDR O.N. - Total Assets Trend (2021–2025)
This chart illustrates how LEPU MED.T.B. SP.GDR O.N.'s total assets have evolved over time, based on quarterly financial data. Also see LEPU MED.T.B. SP.GDR O.N. stock valuation for the company's overall valuation and market capitalisation.
LEPU MED.T.B. SP.GDR O.N. - Asset Composition Analysis
Current Asset Composition (December 2025)
LEPU MED.T.B. SP.GDR O.N.'s total assets of €25.59 Billion consist of 38.2% current assets and 61.8% non-current assets. Review debt load of LEPU MED.T.B. SP.GDR O.N. to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 17.0% |
| Accounts Receivable | €1.99 Billion | 7.6% |
| Inventory | €2.02 Billion | 7.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €3.09 Billion | 11.8% |
| Goodwill | €3.62 Billion | 13.9% |
Asset Composition Trend (2021–2025)
This chart illustrates how LEPU MED.T.B. SP.GDR O.N.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of LEPU MED.T.B. SP.GDR O.N. for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LEPU MED.T.B. SP.GDR O.N.'s current assets represent 38.2% of total assets in 2025, a decrease from 39.4% in 2021.
- Cash Position: Cash and equivalents constituted 17.0% of total assets in 2025, down from 18.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, a decrease from 25.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 13.9% of total assets.
LEPU MED.T.B. SP.GDR O.N. Competitors by Total Assets
Key competitors of LEPU MED.T.B. SP.GDR O.N. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
COPLAND ROAD CAPITAL NEW
F:A2P
|
Germany | €605.37 Million |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
LEPU MED.T.B. SP.GDR O.N. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.38 | 1.82 | 2.74 |
| Quick Ratio | 1.88 | 1.42 | 2.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €5.35 Billion | €4.05 Billion | €5.86 Billion |
LEPU MED.T.B. SP.GDR O.N. - Advanced Valuation Insights
This section examines the relationship between LEPU MED.T.B. SP.GDR O.N.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.63 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.4% |
| Total Assets | €26.14 Billion |
| Market Capitalization | $160.91K USD |
Valuation Analysis
Below Book Valuation: The market values LEPU MED.T.B. SP.GDR O.N.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: LEPU MED.T.B. SP.GDR O.N.'s assets grew by 6.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for LEPU MED.T.B. SP.GDR O.N. (2021–2025)
The table below shows the annual total assets of LEPU MED.T.B. SP.GDR O.N. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €26.14 Billion ≈ $30.56 Billion |
+6.37% |
| 2024-12-31 | €24.57 Billion ≈ $28.73 Billion |
-1.80% |
| 2023-12-31 | €25.02 Billion ≈ $29.25 Billion |
+2.19% |
| 2022-12-31 | €24.48 Billion ≈ $28.63 Billion |
+18.29% |
| 2021-12-31 | €20.70 Billion ≈ $24.20 Billion |
-- |
About LEPU MED.T.B. SP.GDR O.N.
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more